INCB047986 in Rheumatoid Arthritis

NCT02151474 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision.

Conditions

Rheumatoid Arthritis

Interventions

DRUG: INCB047986
DRUG: Placebo

Sponsor

Incyte Corporation